128 related articles for article (PubMed ID: 37557065)
1. Validated LC-MS/MS method for simultaneous quantification of KRAS
Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
J Pharm Biomed Anal; 2023 Oct; 235():115612. PubMed ID: 37557065
[TBL] [Abstract][Full Text] [Related]
2. Quantification of KRAS inhibitor sotorasib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122718. PubMed ID: 33957355
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of an LC-MS/MS method for the quantification of KRAS
Retmana IA; Çelebi N; Rijmers J; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123964. PubMed ID: 38103305
[TBL] [Abstract][Full Text] [Related]
4. Validation of an LC-MS/MS method for the determination of sotorasib, a KRAS
Wong P; Akrami A; Houk B; Vuu I; James CA
Bioanalysis; 2022 Oct; 14(19):1281-1292. PubMed ID: 36473022
[No Abstract] [Full Text] [Related]
5. Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs.
Kruithof PD; de Beer YM; Gulikers JL; Stolk LML; Hendriks LEL; Croes S; van Geel RMJM
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Dec; 1231():123918. PubMed ID: 37979367
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an HPLC-MS/MS method to quantify the KRAS inhibitor adagrasib in mouse plasma and tissue-related matrices.
Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
Biomed Chromatogr; 2023 Nov; 37(11):e5720. PubMed ID: 37596864
[TBL] [Abstract][Full Text] [Related]
7. Quantification of FGFR4 inhibitor BLU-554 in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Dogan-Topal B; Li W; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():116-123. PubMed ID: 30802754
[TBL] [Abstract][Full Text] [Related]
8. Validated HPLC-MS/MS method for quantitation of AMG 510, a KRAS G12C inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice.
Madhyastha N; Samantha SK; Dittakavi S; Markose M; Mallurwar SR; Zainuddin M; Mullangi R
Biomed Chromatogr; 2021 Apr; 35(4):e5043. PubMed ID: 33283304
[TBL] [Abstract][Full Text] [Related]
9. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
10. Bioanalytical assay for the new-generation ROS1/TRK/ALK inhibitor repotrectinib in mouse plasma and tissue homogenate using liquid chromatography-tandem mass spectrometry.
Li W; Perpinioti N; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122098. PubMed ID: 32278292
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
Gao H; Cheng M; Liu H; Ding L
J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous quantification of vortioxetine, fluoxetine and their metabolites in rat plasma by UPLC-MS/MS.
Wang Q; Chen Z; Chen D; Luo S; Xie L
Biomed Chromatogr; 2020 Dec; 34(12):e4960. PubMed ID: 32729624
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium.
Bruin MAC; Rosing H; Lucas L; Wang J; Huitema ADR; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121723. PubMed ID: 31352204
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of lovastatin and its metabolite lovastatin acid in rat plasma using UPLC-MS/MS with positive/negative ion-switching electrospray ionization: Application to a pharmacokinetic study of lovastatin nanosuspension.
Guo M; Zhao L; Li M; Fu Q; Pu X; Liu B; He Z; Yang L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():55-61. PubMed ID: 27200472
[TBL] [Abstract][Full Text] [Related]
15. Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Susam MM; Wang J; Schinkel AH; Beijnen JH; Sparidans RW
Biomed Chromatogr; 2022 Nov; 36(11):e5457. PubMed ID: 35855648
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
18. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification and pharmacokinetic investigation of selexipag and its main metabolite ACT-333679 in rat plasma by UPLC-MS/MS method.
Xie S; Shi L; Chen J; Xu RA; Ye X
J Pharm Biomed Anal; 2020 Oct; 190():113496. PubMed ID: 32768890
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
